Free Trial

Sabre (SABR) Financials

Sabre logo
$1.71 -0.12 (-6.56%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$1.74 +0.03 (+1.46%)
As of 05/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Sabre

Annual Income Statements for Sabre

This table shows Sabre's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
545 243 243 338 159 -1,290 -950 -457 -542 -279 525
Consolidated Net Income / (Loss)
549 247 248 343 163 -1,281 -926 -433 -528 -279 524
Net Income / (Loss) Continuing Operations
235 241 250 341 164 -1,284 -924 -432 -492 -272 -255
Total Pre-Tax Income
354 328 378 398 200 -1,305 -938 -423 -458 -267 -239
Total Operating Income
460 460 493 562 363 -988 -665 -261 32 242 295
Total Gross Profit
1,017 1,086 1,085 2,213 2,249 755 997 1,496 1,566 1,599 1,564
Total Revenue
2,961 3,373 3,598 3,867 3,975 1,334 1,689 2,537 2,642 2,745 2,771
Operating Revenue
2,961 3,373 3,598 3,867 3,975 1,334 1,689 2,537 2,642 2,745 2,771
Total Cost of Revenue
1,944 2,288 2,514 1,654 1,726 579 691 1,041 1,076 1,146 1,207
Operating Cost of Revenue
1,944 2,288 2,514 1,654 1,726 579 691 1,041 1,076 1,146 1,207
Total Operating Expenses
557 626 591 1,651 1,885 1,743 1,663 1,757 1,534 1,357 1,269
Selling, General & Admin Expense
557 626 510 552 600 586 610 661 583 576 557
Other Operating Expenses / (Income)
- - - 1,099 1,285 1,157 1,053 1,096 951 781 711
Total Other Income / (Expense), net
-106 -132 -116 -164 -164 -317 -273 -162 -490 -509 -535
Interest Expense
212 162 155 158 156 247 271 4.47 109 38 91
Interest & Investment Income
15 2.78 2.58 2.56 2.04 -2.53 -0.26 -295 -395 -451 -444
Other Income / (Expense), net
91 28 37 -8.51 -9.43 -67 -1.75 137 13 -21 0.39
Income Tax Expense
119 87 128 57 35 -21 -15 8.67 34 4.11 16
Net Income / (Loss) Discontinued Operations
314 5.55 -1.93 1.74 -1.77 2.79 -2.53 -0.68 -36 -7.14 779
Preferred Stock Dividends Declared
- - - 0.00 0.00 7.66 22 21 14 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
3.48 4.38 5.11 5.13 3.95 1.20 2.16 2.67 -0.33 0.08 -0.66
Basic Earnings per Share
$2.00 $0.87 $0.87 $1.23 $0.57 ($4.45) ($2.96) ($1.40) ($1.56) ($0.73) $1.34
Weighted Average Basic Shares Outstanding
273.14M 277.55M 276.89M 275.24M 274.17M 289.86M 320.92M 326.74M 346.57M 383.73M 391.71M
Diluted Earnings per Share
$1.95 $0.86 $0.87 $1.22 $0.57 ($4.45) ($2.96) ($1.40) ($1.56) ($0.73) $1.34
Weighted Average Diluted Shares Outstanding
280.07M 282.75M 278.32M 277.52M 276.22M 289.86M 320.92M 326.74M 346.57M 383.73M 391.71M
Weighted Average Basic & Diluted Shares Outstanding
272.70M 278.80M 278.80M 274.40M 273.75M 317.33M 323.52M 328.59M 379.48M 386.01M 395.17M

Quarterly Income Statements for Sabre

This table shows Sabre's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-212 -96 -71 -70 -63 -75 35 -256 849 -103 8.12
Consolidated Net Income / (Loss)
-208 -96 -71 -69 -63 -75 36 -257 848 -104 8.01
Net Income / (Loss) Continuing Operations
-208 -97 -71 -70 -62 -75 -3.38 -201 48 -138 9.39
Total Pre-Tax Income
-199 -79 -68 -64 -55 -91 -15 -110 -10 -98 -2.00
Total Operating Income
52 37 98 49 58 57 91 89 94 9.34 116
Total Gross Profit
446 415 462 402 397 425 397 391 402 328 425
Total Revenue
740 687 783 695 691 715 702 687 715 592 760
Operating Revenue
740 687 783 695 691 715 702 687 715 592 760
Total Cost of Revenue
294 272 321 293 295 290 305 296 313 264 335
Operating Cost of Revenue
294 272 321 293 295 290 305 296 313 264 335
Total Operating Expenses
394 378 364 353 339 368 305 302 308 319 309
Selling, General & Admin Expense
151 140 141 154 149 155 130 129 140 144 134
Other Operating Expenses / (Income)
243 237 222 199 189 213 175 172 168 174 175
Total Other Income / (Expense), net
-252 -116 -166 -113 -113 -148 -106 -199 -104 -107 -118
Interest Expense
121 -100 38 0.00 0.00 -125 0.00 85 0.00 5.50 2.73
Interest & Investment Income
-119 -222 -124 -116 -113 -252 -109 -111 -111 -94 -122
Other Income / (Expense), net
-12 5.67 -4.48 3.43 -0.33 -21 2.71 -3.20 6.93 -7.11 7.00
Income Tax Expense
8.46 18 2.93 5.92 7.24 -16 -12 91 -59 41 -11
Net Income / (Loss) Discontinued Operations
-0.12 0.83 0.00 0.25 -0.72 - 39 -56 800 35 -1.39
Net Income / (Loss) Attributable to Noncontrolling Interest
0.38 0.19 0.38 0.28 -0.32 -0.26 0.21 -0.17 -0.27 -0.43 -0.11
Basic Earnings per Share
($0.61) ($0.24) ($0.19) ($0.18) ($0.16) ($0.20) $0.09 ($0.65) $2.15 ($0.25) $0.02
Weighted Average Basic Shares Outstanding
345.13M 346.57M 379.77M 383.51M 385.73M 383.73M 386.27M 390.91M 394.58M 391.71M 395.15M
Diluted Earnings per Share
($0.61) ($0.24) ($0.19) ($0.18) ($0.16) ($0.20) $0.09 ($0.65) $1.98 ($0.08) $0.02
Weighted Average Diluted Shares Outstanding
345.13M 346.57M 379.77M 383.51M 385.73M 383.73M 386.27M 390.91M 429.25M 391.71M 397.56M
Weighted Average Basic & Diluted Shares Outstanding
379.48M 379.48M 381.93M 385.70M 385.85M 386.01M 387.81M 394.51M 394.88M 395.17M 395.31M

Annual Cash Flow Statements for Sabre

This table details how cash moves in and out of Sabre's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
165 43 -1.12 141 -73 1,063 -500 -183 -147 76 165
Net Cash From Operating Activities
529 699 678 725 581 -770 -415 -276 67 70 -109
Net Cash From Continuing Operating Activities
529 699 678 725 581 -770 -415 -276 67 70 -109
Net Income / (Loss) Continuing Operations
235 241 250 341 164 -1,284 -924 -432 -492 -272 -255
Consolidated Net Income / (Loss)
549 247 248 343 163 -1,281 -926 -433 -528 -279 524
Net Income / (Loss) Discontinued Operations
314 5.55 -1.93 1.74 -1.77 2.79 -2.53 -0.68 -36 -7.14 779
Depreciation Expense
351 414 401 413 415 364 262 185 121 110 106
Amortization Expense
50 65 73 82 87 84 70 60 55 61 67
Non-Cash Adjustments To Reconcile Net Income
-39 58 163 74 75 230 117 -69 265 165 -59
Changes in Operating Assets and Liabilities, net
-69 -79 -209 -185 -160 -164 60 -20 118 6.31 32
Net Cash From Investing Activities
-729 -446 -318 -275 -243 -1.29 -29 174 -91 -25 -74
Net Cash From Continuing Investing Activities
-729 -446 -318 -275 -243 -1.29 -29 174 -91 -25 -74
Purchase of Property, Plant & Equipment
-287 -328 -316 -284 -115 -65 -54 -69 -81 -80 -83
Purchase of Investments
- - - - - 0.00 0.00 -80 -11 0.00 0.00
Sale of Property, Plant & Equipment
- - - 0.00 - 69 25 392 0.00 0.00 9.27
Sale and/or Maturity of Investments
0.00 46 - - 0.00 - - - 0.00 55 0.00
Other Investing Activities, net
0.00 0.00 -1.09 8.68 -20 -4.38 0.00 0.00 0.66 -0.30 -0.20
Net Cash From Financing Activities
93 -190 -357 -307 -410 1,838 -51 -75 -94 40 -686
Net Cash From Continuing Financing Activities
93 -190 -357 -307 -410 1,838 -51 -75 -94 40 -688
Repayment of Debt
-1,013 -1,011 -1,904 -69 -116 -1,620 -1,077 -1,856 -1,838 -1,892 -3,899
Payment of Dividends
-99 -144 -155 -154 -154 -44 -22 -21 -16 0.00 0.00
Issuance of Debt
1,252 1,055 1,898 0.00 45 2,982 1,070 1,819 1,749 1,939 3,221
Other Financing Activities, net
4.58 -17 -87 -57 -107 -78 -23 -16 10 -6.67 -10
Effect of Exchange Rate Changes
-6.93 -1.11 - - 0.78 - -2.14 -2.36 1.71 -4.28 4.45
Other Net Changes in Cash
279 -19 -4.85 -1.90 -2.38 -2.93 -3.50 -3.26 -30 -4.28 1,029
Cash Interest Paid
166 165 161 165 163 189 249 288 400 391 595

Quarterly Cash Flow Statements for Sabre

This table details how cash moves in and out of Sabre's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-105 47 -19 -17 56 56 -73 -225 236 227 -246
Net Cash From Operating Activities
59 96 -68 28 28 83 -64 -201 34 139 -134
Net Cash From Continuing Operating Activities
59 96 -68 28 28 83 -64 -201 34 139 -134
Net Income / (Loss) Continuing Operations
-208 -97 -71 -69 -63 -75 -3.38 -240 48 -99 9.39
Consolidated Net Income / (Loss)
-208 -96 -71 -69 -63 -75 36 -257 848 -104 8.01
Net Income / (Loss) Discontinued Operations
-0.12 0.83 - - - - 39 - 800 -4.27 -1.39
Depreciation Expense
37 35 34 31 33 31 25 21 27 28 26
Amortization Expense
13 15 15 16 16 17 17 15 17 17 20
Non-Cash Adjustments To Reconcile Net Income
175 49 88 19 31 33 30 -112 1.87 14 5.85
Changes in Operating Assets and Liabilities, net
42 95 -134 31 11 77 -133 114 -60 180 -196
Net Cash From Investing Activities
-19 -29 -28 -20 35 -16 -7.23 -22 -20 -23 -21
Net Cash From Continuing Investing Activities
-19 -29 -28 -20 35 -16 -7.23 -22 -20 -23 -21
Purchase of Property, Plant & Equipment
-20 -19 -28 -20 -20 -16 -17 -21 -20 -23 -21
Sale of Property, Plant & Equipment
- - 0.00 - - - 9.64 -0.37 - - 0.00
Net Cash From Financing Activities
-143 -22 78 -24 -8.08 -6.48 13 21 -839 119 -92
Net Cash From Continuing Financing Activities
-143 -22 78 -24 -8.08 -6.48 13 21 -844 121 -92
Repayment of Debt
-1,021 -32 -260 -26 -17 -1,589 -25 -1,309 -898 -1,666 -168
Issuance of Debt
883 10 340 6.30 9.30 1,583 41 1,338 55 1,787 73
Other Financing Activities, net
0.10 -0.08 -2.08 -4.33 -0.20 -0.06 -2.44 -7.53 -0.33 -0.11 3.03
Effect of Exchange Rate Changes
-1.76 1.91 -1.21 -0.45 1.84 -4.45 2.30 - 0.93 0.06 -1.53
Other Net Changes in Cash
-0.23 -0.28 - - - - -18 -27 1,060 -7.18 3.42

Annual Balance Sheets for Sabre

This table presents Sabre's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,394 5,725 5,649 5,806 5,690 6,078 5,291 4,963 4,672 4,635 4,502
Total Current Assets
778 853 961 1,188 1,122 1,888 1,402 1,361 1,159 1,163 1,296
Cash & Equivalents
321 364 361 509 436 1,500 978 795 648 724 792
Restricted Cash
- - - - - 0.00 21 21 21 21 119
Accounts Receivable
376 401 491 508 547 255 260 354 343 287 312
Prepaid Expenses
81 89 109 170 139 133 122 192 146 77 74
Plant, Property, & Equipment, net
628 753 799 790 0.00 363 250 229 234 234 255
Total Noncurrent Assets
3,988 4,118 3,889 3,828 4,568 3,826 3,639 3,372 3,280 3,238 2,951
Long-Term Investments
24 26 28 28 27 24 23 22 22 22 23
Goodwill
2,440 2,548 2,555 2,552 2,633 2,637 2,470 2,542 2,554 2,383 2,384
Intangible Assets
837 775 683 613 574 511 441 410 376 315 285
Noncurrent Deferred & Refundable Income Taxes
44 95 32 24 22 24 27 39 10 8.11 3.87
Other Noncurrent Operating Assets
642 673 592 611 1,312 630 475 358 317 273 255
Total Liabilities & Shareholders' Equity
5,394 5,725 5,649 5,806 5,690 6,078 5,291 4,963 4,672 4,635 4,502
Total Liabilities
4,909 5,099 4,951 4,832 4,742 5,793 5,791 5,836 6,034 6,227 5,527
Total Current Liabilities
1,000 1,166 972 1,018 1,026 622 717 816 915 1,142 1,214
Short-Term Debt
190 169 57 68 82 26 29 23 4.04 230 246
Accounts Payable
138 169 163 165 187 115 123 171 232 243 260
Accrued Expenses
407 439 470 487 506 294 326 432 435 452 546
Current Deferred Revenue
165 187 111 81 85 99 81 67 108 60 58
Current Employee Benefit Liabilities
99 102 112 113 94 87 136 122 136 106 104
Total Noncurrent Liabilities
3,909 3,933 3,979 3,814 3,717 5,171 5,075 5,020 5,119 5,085 4,313
Long-Term Debt
3,169 3,276 3,399 3,337 3,262 4,718 4,724 4,717 4,829 4,835 4,103
Noncurrent Deferred & Payable Income Tax Liabilities
84 89 100 136 107 72 38 39 31 30 37
Other Noncurrent Operating Liabilities
656 567 480 340 348 381 297 264 259 204 173
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - 0.00 14 13 12
Total Equity & Noncontrolling Interests
484 626 699 974 948 285 -500 -873 -1,376 -1,605 -1,036
Total Preferred & Common Equity
483 623 693 967 939 278 -509 -884 -1,388 -1,619 -1,051
Total Common Equity
483 623 693 967 939 278 -509 -884 -1,388 -1,619 -1,051
Common Stock
2,019 2,109 2,177 2,246 2,320 2,988 3,119 3,202 3,254 3,309 3,355
Retained Earnings
-1,329 -1,141 -1,053 -769 -763 -2,100 -3,050 -3,507 -4,048 -4,327 -3,803
Treasury Stock
-111 -222 -342 -378 -469 -475 -498 -514 -520 -527 -537
Accumulated Other Comprehensive Income / (Loss)
-97 -123 -88 -133 -149 -136 -80 -66 -74 -74 -67
Noncontrolling Interest
1.44 2.58 5.20 7.21 8.59 7.03 9.19 12 13 14 15

Quarterly Balance Sheets for Sabre

This table presents Sabre's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
5,020 5,026 4,925 4,742 4,738 4,666 4,693 4,678 4,419 4,373 4,333
Total Current Assets
1,393 1,442 1,346 1,196 1,227 1,166 1,196 1,224 953 1,157 1,134
Cash & Equivalents
783 817 706 602 629 613 669 651 426 662 644
Restricted Cash
21 21 21 21 21 21 21 21 21 21 21
Accounts Receivable
401 414 441 393 411 376 409 397 329 380 367
Prepaid Expenses
188 190 177 180 165 156 97 155 105 95 102
Plant, Property, & Equipment, net
232 231 234 234 243 248 250 251 245 249 261
Total Noncurrent Assets
3,395 3,353 3,345 3,312 3,268 3,251 3,248 3,203 3,222 2,967 2,938
Long-Term Investments
22 23 21 22 23 22 22 23 22 22 23
Goodwill
2,528 2,543 2,558 2,552 2,553 2,554 2,557 2,550 2,385 2,384 2,383
Intangible Assets
423 401 391 386 366 357 348 329 301 293 277
Noncurrent Deferred & Refundable Income Taxes
36 38 36 31 12 12 11 6.14 6.87 7.04 4.52
Other Noncurrent Operating Assets
386 348 337 322 313 307 309 295 262 261 250
Total Liabilities & Shareholders' Equity
5,020 5,026 4,925 4,742 4,738 4,666 4,693 4,678 4,419 4,373 4,333
Total Liabilities
5,752 5,975 5,993 6,010 6,154 6,143 6,223 6,225 6,212 5,313 5,347
Total Current Liabilities
738 864 899 908 893 1,086 1,173 1,117 947 1,018 1,225
Short-Term Debt
23 23 4.04 4.04 3.17 218 245 233 43 153 355
Accounts Payable
135 192 217 215 250 237 244 259 247 219 208
Accrued Expenses
391 491 468 477 458 459 494 491 489 532 525
Current Deferred Revenue
75 68 85 91 100 82 79 72 57 55 55
Current Employee Benefit Liabilities
114 89 126 121 81 91 112 62 59 59 84
Total Noncurrent Liabilities
5,014 5,111 5,094 5,102 5,261 5,057 5,050 5,108 5,265 4,294 4,121
Long-Term Debt
4,719 4,831 4,798 4,817 4,985 4,789 4,790 4,885 4,997 4,063 3,912
Noncurrent Deferred & Payable Income Tax Liabilities
27 28 28 29 28 28 31 22 59 41 36
Other Noncurrent Operating Liabilities
268 252 269 256 249 240 229 201 195 190 173
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- 16 15 15 14 14 13 12 12 11 12
Total Equity & Noncontrolling Interests
-732 -965 -1,084 -1,283 -1,430 -1,491 -1,543 -1,559 -1,804 -951 -1,026
Total Preferred & Common Equity
-743 -976 -1,095 -1,295 -1,444 -1,505 -1,558 -1,574 -1,820 -967 -1,041
Total Common Equity
-743 -976 -1,095 -1,295 -1,444 -1,505 -1,558 -1,574 -1,820 -967 -1,041
Common Stock
3,189 3,219 3,228 3,242 3,268 3,280 3,295 3,322 3,335 3,344 3,358
Retained Earnings
-3,341 -3,611 -3,740 -3,952 -4,120 -4,190 -4,252 -4,292 -4,548 -3,699 -3,794
Treasury Stock
-514 -520 -520 -520 -522 -527 -527 -529 -537 -537 -537
Accumulated Other Comprehensive Income / (Loss)
-77 -64 -63 -64 -70 -69 -73 -75 -70 -74 -67
Noncontrolling Interest
11 11 12 12 14 14 14 15 15 16 15

Annual Metrics And Ratios for Sabre

This table displays calculated financial ratios and metrics derived from Sabre's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 394,884,884.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 394,884,884.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.33
Growth Metrics
- - - - - - - - - - -
Revenue Growth
12.52% 13.93% 6.67% 7.46% 2.79% -66.44% 26.59% 50.22% 14.61% 4.19% 0.95%
EBITDA Growth
36.37% 1.43% 3.90% 4.41% -18.40% -170.95% 44.72% 135.87% 122.01% 71.25% 19.65%
EBIT Growth
54.17% -11.60% 8.78% 4.44% -36.05% -398.04% 36.76% 81.35% 148.94% 334.48% 33.75%
NOPAT Growth
-23.58% 10.98% -3.56% 47.46% -37.80% -331.23% 32.65% 60.77% 118.06% 507.00% 22.18%
Net Income Growth
662.93% -55.02% 0.29% 38.37% -52.56% -888.17% 27.70% 53.28% -21.99% 47.21% 288.01%
EPS Growth
747.83% -55.90% 1.16% 40.23% -53.28% -880.70% 33.48% 52.70% -11.43% 53.21% 283.56%
Operating Cash Flow Growth
36.51% 32.16% -3.06% 6.90% -19.80% -232.51% 46.17% 33.33% 120.34% 25.53% -254.97%
Free Cash Flow Firm Growth
-168.91% 142.62% 56.15% 66.55% -21.93% -217.30% 98.93% -4,185.20% 266.87% -2.27% -36.36%
Invested Capital Growth
23.62% 5.23% 2.28% 2.06% -0.41% -8.42% -13.18% -0.45% -8.22% -2.71% -3.66%
Revenue Q/Q Growth
3.94% 2.16% 1.47% 1.10% 0.44% -32.00% 12.45% 5.42% 1.96% 0.92% 0.60%
EBITDA Q/Q Growth
11.71% -1.89% 12.28% -5.74% -7.48% -91.60% 13.31% 87.86% 54.10% -1.90% -2.67%
EBIT Q/Q Growth
14.97% -6.42% 26.75% -10.89% -16.30% -34.19% 11.23% 36.75% 252.68% -2.63% -5.05%
NOPAT Q/Q Growth
-23.19% -2.67% 3.94% 16.41% -21.75% -38.99% 12.33% 21.40% 204.77% 7.41% -8.62%
Net Income Q/Q Growth
17.93% -29.78% 30.42% 0.61% -31.51% -34.70% 12.56% 5.84% 10.67% 7.10% -5.17%
EPS Q/Q Growth
14.04% -28.93% 27.94% 1.67% -32.14% -30.88% 12.68% 5.41% 14.29% 5.19% 9.84%
Operating Cash Flow Q/Q Growth
7.60% 22.27% -6.19% -4.42% -5.17% -79.05% 29.88% 13.95% 3,928.39% -15.83% 36.87%
Free Cash Flow Firm Q/Q Growth
-132.70% 236.09% -36.10% 15.89% -30.03% -22.04% 98.39% -107.09% 15.29% -8.59% -33.58%
Invested Capital Q/Q Growth
2.19% -5.23% -1.42% -1.07% 0.27% -3.23% -8.76% -4.87% -4.40% -3.16% -7.01%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.34% 32.19% 30.14% 57.22% 56.57% 56.60% 59.06% 58.97% 59.09% 58.58% 56.44%
EBITDA Margin
32.18% 28.65% 27.91% 27.11% 21.52% -45.49% -19.87% 4.74% 9.19% 15.10% 16.91%
Operating Margin
15.53% 13.62% 13.71% 14.53% 9.14% -74.06% -39.40% -10.29% 1.62% 9.45% 10.66%
EBIT Margin
18.61% 14.44% 14.73% 14.31% 8.91% -79.08% -39.51% -4.90% 2.09% 8.73% 10.68%
Profit (Net Income) Margin
18.54% 7.32% 6.88% 8.86% 4.09% -96.03% -54.85% -17.06% -18.16% -9.20% 18.91%
Tax Burden Percent
155.12% 75.28% 65.58% 86.01% 81.42% 98.18% 98.71% 102.21% 106.97% 99.37% -219.02%
Interest Burden Percent
64.21% 67.33% 71.25% 71.98% 56.40% 123.69% 140.64% 340.34% -810.46% -106.01% -80.85%
Effective Tax Rate
33.72% 26.41% 33.91% 14.43% 17.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
9.63% 9.42% 8.76% 12.64% 7.80% -18.86% -14.23% -6.02% 1.14% 7.30% 8.49%
ROIC Less NNEP Spread (ROIC-NNEP)
18.11% 6.41% 6.20% 7.98% 3.05% -38.19% -27.85% -12.74% -12.81% -4.05% 16.96%
Return on Net Nonoperating Assets (RNNOA)
183.49% 35.08% 28.65% 28.33% 9.12% -188.97% 877.66% 69.08% 46.12% 11.57% -48.54%
Return on Equity (ROE)
193.12% 44.50% 37.41% 40.97% 16.91% -207.84% 863.44% 63.06% 47.26% 18.87% -40.06%
Cash Return on Invested Capital (CROIC)
-11.50% 4.32% 6.50% 10.60% 8.21% -10.07% -0.12% -5.56% 9.71% 10.05% 12.22%
Operating Return on Assets (OROA)
10.98% 8.76% 9.32% 9.66% 6.16% -17.93% -11.74% -2.43% 1.26% 5.69% 6.48%
Return on Assets (ROA)
10.94% 4.44% 4.35% 5.98% 2.83% -21.77% -16.30% -8.44% -10.96% -5.99% 11.47%
Return on Common Equity (ROCE)
192.42% 44.34% 37.19% 40.67% 16.78% -205.20% 928.97% 64.02% 48.07% 19.22% -40.88%
Return on Equity Simple (ROE_SIMPLE)
113.73% 39.63% 35.72% 35.43% 17.31% -460.63% 182.02% 48.94% 38.02% 17.21% 0.00%
Net Operating Profit after Tax (NOPAT)
305 338 326 481 299 -692 -466 -183 33 200 207
NOPAT Margin
10.29% 10.03% 9.06% 12.44% 7.52% -51.84% -27.58% -7.20% 1.13% 6.61% 7.46%
Net Nonoperating Expense Percent (NNEP)
-8.48% 3.01% 2.56% 4.66% 4.75% 19.33% 13.62% 6.72% 13.95% 11.35% -8.47%
Return On Investment Capital (ROIC_SIMPLE)
7.93% 8.31% 7.85% 10.98% 6.97% -13.75% -10.95% -4.72% 0.95% 5.79% 6.24%
Cost of Revenue to Revenue
65.66% 67.82% 69.86% 42.78% 43.43% 43.40% 40.94% 41.03% 40.91% 41.42% 43.56%
SG&A Expenses to Revenue
18.81% 18.56% 14.17% 14.27% 15.10% 43.96% 36.12% 26.06% 21.82% 20.55% 20.12%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
18.81% 18.56% 16.43% 42.68% 47.43% 130.66% 98.46% 69.26% 57.47% 49.14% 45.78%
Earnings before Interest and Taxes (EBIT)
551 487 530 554 354 -1,055 -667 -124 61 265 296
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
953 967 1,004 1,048 856 -607 -335 120 267 457 469
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
14.23 10.12 7.53 5.85 6.37 13.71 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.32 1.87 1.45 1.46 1.50 2.86 1.65 0.80 0.57 0.46 0.19
Price to Earnings (P/E)
12.59 26.00 21.53 16.75 37.71 0.00 0.00 0.00 0.00 0.00 1.02
Dividend Yield
1.46% 2.31% 2.95% 2.73% 2.56% 4.66% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.94% 3.85% 4.64% 5.97% 2.65% 0.00% 0.00% 0.00% 0.00% 0.00% 97.69%
Enterprise Value to Invested Capital (EV/IC)
2.83 2.54 2.20 2.22 2.32 2.01 2.14 1.96 2.10 2.12 1.66
Enterprise Value to Revenue (EV/Rev)
3.34 2.78 2.31 2.21 2.23 5.28 3.86 2.34 2.01 1.89 1.44
Enterprise Value to EBITDA (EV/EBITDA)
10.37 9.69 8.26 8.14 10.37 0.00 0.00 49.39 21.86 12.53 8.49
Enterprise Value to EBIT (EV/EBIT)
17.93 19.22 15.65 15.41 25.05 0.00 0.00 0.00 95.88 21.67 13.45
Enterprise Value to NOPAT (EV/NOPAT)
32.43 27.69 25.43 17.74 29.65 0.00 0.00 0.00 176.93 28.62 19.24
Enterprise Value to Operating Cash Flow (EV/OCF)
18.67 13.39 12.23 11.77 15.26 0.00 0.00 0.00 103.82 81.21 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 60.40 34.26 21.15 28.17 0.00 0.00 0.00 20.71 20.80 13.37
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
6.94 5.51 4.95 3.50 3.53 16.64 -9.51 -5.43 -3.55 -3.18 -4.25
Long-Term Debt to Equity
6.55 5.24 4.87 3.43 3.44 16.54 -9.45 -5.40 -3.55 -3.04 -4.01
Financial Leverage
10.13 5.47 4.62 3.55 2.99 4.95 -31.52 -5.42 -3.60 -2.86 -2.86
Leverage Ratio
17.65 10.02 8.59 6.85 5.98 9.55 -52.99 -7.47 -4.31 -3.15 -3.49
Compound Leverage Factor
11.34 6.75 6.12 4.93 3.37 11.81 -74.52 -25.43 34.95 3.34 2.82
Debt to Total Capital
87.40% 84.63% 83.19% 77.76% 77.92% 94.33% 111.75% 122.57% 139.21% 145.83% 130.82%
Short-Term Debt to Total Capital
4.95% 4.16% 1.38% 1.56% 1.90% 0.52% 0.69% 0.61% 0.12% 6.63% 7.39%
Long-Term Debt to Total Capital
82.45% 80.48% 81.81% 76.19% 76.01% 93.81% 111.06% 121.96% 139.10% 139.20% 123.43%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.04% 0.06% 0.13% 0.16% 0.20% 0.14% 0.22% 0.30% 0.78% 0.79% 0.80%
Common Equity to Total Capital
12.56% 15.30% 16.69% 22.08% 21.88% 5.53% -11.97% -22.87% -39.99% -46.62% -31.61%
Debt to EBITDA
3.53 3.56 3.44 3.25 3.91 -7.82 -14.17 39.40 18.09 11.07 9.28
Net Debt to EBITDA
3.16 3.16 3.05 2.74 3.37 -5.31 -11.12 32.43 15.50 9.39 7.29
Long-Term Debt to EBITDA
3.33 3.39 3.38 3.18 3.81 -7.77 -14.08 39.20 18.08 10.57 8.76
Debt to NOPAT
11.03 10.19 10.60 7.08 11.18 -6.86 -10.20 -25.94 146.47 25.29 21.02
Net Debt to NOPAT
9.89 9.04 9.40 5.97 9.63 -4.66 -8.01 -21.35 125.51 21.45 16.51
Long-Term Debt to NOPAT
10.40 9.69 10.42 6.94 10.91 -6.82 -10.14 -25.81 146.35 24.14 19.84
Altman Z-Score
1.33 1.27 1.32 1.53 1.49 -0.19 -0.46 -0.22 -0.32 -0.32 -0.27
Noncontrolling Interest Sharing Ratio
0.36% 0.36% 0.59% 0.74% 0.82% 1.27% -7.59% -1.51% -1.73% -1.84% -2.06%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.78 0.73 0.99 1.17 1.09 3.04 1.96 1.67 1.27 1.02 1.07
Quick Ratio
0.70 0.66 0.88 1.00 0.96 2.82 1.73 1.41 1.08 0.93 0.91
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-364 155 242 403 315 -369 -3.94 -169 282 276 298
Operating Cash Flow to CapEx
184.59% 213.46% 214.27% 255.26% 504.71% 0.00% -1,409.05% 0.00% 64.33% 240.82% -147.87%
Free Cash Flow to Firm to Interest Expense
-1.72 0.96 1.56 2.56 2.01 -1.49 -0.01 -37.77 2.60 7.25 3.28
Operating Cash Flow to Interest Expense
2.50 4.32 4.38 4.60 3.72 -3.11 -1.53 -61.81 0.52 1.86 -1.20
Operating Cash Flow Less CapEx to Interest Expense
1.14 2.30 2.33 2.80 2.98 -3.10 -1.64 10.35 -0.29 1.09 -2.01
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.59 0.61 0.63 0.68 0.69 0.23 0.30 0.49 0.60 0.65 0.61
Accounts Receivable Turnover
8.02 8.69 8.08 7.74 7.54 3.33 6.55 8.27 8.34 8.87 9.26
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.02 4.89 4.64 4.87 0.00 0.00 5.51 10.59 12.56 12.57 11.33
Accounts Payable Turnover
15.17 14.90 15.17 10.09 9.80 3.83 5.81 7.08 5.91 5.07 4.80
Days Sales Outstanding (DSO)
45.53 42.01 45.20 47.13 48.42 109.71 55.69 44.13 43.75 41.17 39.42
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
24.06 24.49 24.05 36.18 37.26 95.32 62.86 51.55 61.80 72.06 76.06
Cash Conversion Cycle (CCC)
21.47 17.52 21.15 10.95 11.16 14.39 -7.17 -7.42 -18.05 -30.89 -36.64
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,498 3,681 3,765 3,843 3,827 3,505 3,043 3,029 2,780 2,705 2,391
Invested Capital Turnover
0.94 0.94 0.97 1.02 1.04 0.36 0.52 0.84 1.00 1.10 1.14
Increase / (Decrease) in Invested Capital
669 183 84 78 -16 -322 -462 -14 -249 -75 -91
Enterprise Value (EV)
9,883 9,365 8,295 8,530 8,868 7,041 6,518 5,943 5,839 5,733 3,979
Market Capitalization
6,867 6,307 5,223 5,654 5,980 3,814 2,778 2,029 1,670 1,408 537
Book Value per Share
$1.74 $2.22 $2.52 $3.51 $3.43 $0.88 ($1.57) ($2.69) ($3.66) ($4.20) ($2.66)
Tangible Book Value per Share
($10.07) ($9.64) ($9.26) ($7.99) ($8.28) ($9.05) ($10.57) ($11.68) ($11.38) ($11.69) ($9.42)
Total Capital
3,844 4,071 4,154 4,380 4,291 5,029 4,253 3,868 3,472 3,473 3,324
Total Debt
3,360 3,446 3,456 3,406 3,343 4,744 4,753 4,741 4,834 5,065 4,349
Total Long-Term Debt
3,169 3,276 3,399 3,337 3,262 4,718 4,724 4,717 4,829 4,835 4,103
Net Debt
3,014 3,056 3,067 2,869 2,880 3,220 3,731 3,902 4,142 4,297 3,416
Capital Expenditures (CapEx)
287 328 316 284 115 -3.08 29 -323 87 29 74
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-353 -508 -316 -272 -258 -207 -284 -247 -421 -494 -582
Debt-free Net Working Capital (DFNWC)
-32 -144 46 238 178 1,292 715 569 248 252 328
Net Working Capital (NWC)
-222 -313 -11 169 96 1,266 686 546 244 21 82
Net Nonoperating Expense (NNE)
-244 91 78 138 137 590 460 250 561 479 -317
Net Nonoperating Obligations (NNO)
3,014 3,056 3,067 2,869 2,880 3,220 3,543 3,902 4,142 4,297 3,416
Total Depreciation and Amortization (D&A)
402 479 474 495 502 448 332 245 206 193 173
Debt-free, Cash-free Net Working Capital to Revenue
-11.93% -15.05% -8.77% -7.02% -6.50% -15.55% -16.84% -9.72% -14.49% -16.30% -21.00%
Debt-free Net Working Capital to Revenue
-1.08% -4.26% 1.27% 6.15% 4.48% 96.86% 42.34% 22.44% 8.53% 8.31% 11.84%
Net Working Capital to Revenue
-7.51% -9.28% -0.32% 4.38% 2.42% 94.91% 40.61% 21.52% 8.39% 0.71% 2.98%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.00 $0.87 $0.87 $1.23 $0.57 ($4.42) ($2.96) ($1.40) ($1.56) ($0.73) $1.34
Adjusted Weighted Average Basic Shares Outstanding
273.14M 277.55M 276.89M 275.24M 274.17M 289.86M 320.92M 326.74M 346.57M 383.73M 391.71M
Adjusted Diluted Earnings per Share
$1.95 $0.86 $0.87 $1.22 $0.57 ($4.42) ($2.96) ($1.40) ($1.56) ($0.73) $1.34
Adjusted Weighted Average Diluted Shares Outstanding
280.07M 282.75M 278.32M 277.52M 276.22M 289.86M 320.92M 326.74M 346.57M 383.73M 391.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
275.22M 277.13M 274.45M 275.41M 273.75M 317.33M 323.52M 328.59M 379.48M 386.01M 395.17M
Normalized Net Operating Profit after Tax (NOPAT)
305 338 380 481 299 -692 -466 -183 33 200 207
Normalized NOPAT Margin
10.29% 10.03% 10.55% 12.44% 7.52% -51.84% -27.58% -7.20% 1.13% 6.61% 7.46%
Pre Tax Income Margin
11.95% 9.72% 10.49% 10.30% 5.02% -97.81% -55.56% -16.69% -16.97% -9.26% -8.63%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.60 3.01 3.42 3.51 2.26 -4.26 -2.46 -27.81 0.56 6.96 3.26
NOPAT to Interest Expense
1.44 2.09 2.10 3.05 1.91 -2.80 -1.72 -40.85 0.30 5.27 2.28
EBIT Less CapEx to Interest Expense
1.25 0.99 1.38 1.71 1.53 -4.25 -2.57 44.35 -0.24 6.19 2.45
NOPAT Less CapEx to Interest Expense
0.09 0.07 0.06 1.25 1.18 -2.78 -1.83 31.31 -0.50 4.50 1.47
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.96% 58.46% 62.53% 44.97% 94.44% -3.47% -2.34% -4.94% -3.04% 0.00% 0.00%
Augmented Payout Ratio
35.95% 98.95% 106.59% 52.64% 142.20% -3.47% -2.34% -4.94% -3.04% 0.00% 0.00%

Quarterly Metrics And Ratios for Sabre

This table displays calculated financial ratios and metrics derived from Sabre's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - 387,806,562.00 394,514,384.00 394,884,884.00 395,165,033.00
DEI Adjusted Shares Outstanding
- - - - - - - 387,806,562.00 394,514,384.00 394,884,884.00 395,165,033.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - -0.66 2.15 -0.26 0.02
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.62% 8.85% 5.41% 4.03% 3.28% 4.03% -0.80% -1.14% 3.45% 2.85% 8.29%
EBITDA Growth
1,577.26% 7,606.49% 151.24% 309.33% 32.28% -9.59% 8.47% 39.35% 42.74% -21.33% 24.41%
EBIT Growth
163.30% 174.44% 4,166.55% 356.86% 74.66% -16.64% 14.49% 64.78% 74.83% -87.60% 30.62%
NOPAT Growth
192.33% 168.14% 46,149.30% 244.26% 34.34% 52.90% 5.42% 82.94% 61.87% -74.90% 26.83%
Net Income Growth
-54.46% 39.59% 28.73% 43.96% 69.63% 22.13% 149.99% -269.19% 1,443.95% -38.12% -77.47%
EPS Growth
-41.86% 52.00% 40.63% 53.85% 73.77% 16.67% 147.37% -261.11% 1,337.50% 60.00% -77.78%
Operating Cash Flow Growth
157.98% 150.63% 5.96% 205.05% -53.19% -13.83% -18.38% -626.33% 38.10% 83.97% -109.75%
Free Cash Flow Firm Growth
180.78% 1,219.20% 502.50% 63.56% -47.52% -58.12% -56.31% 184.12% 84.86% -70.00% 357.68%
Invested Capital Growth
-8.67% -8.22% -4.83% -3.68% -3.95% -2.71% -0.76% -12.05% -7.94% -3.66% -10.84%
Revenue Q/Q Growth
0.40% -7.21% 13.95% -2.00% -0.33% -6.54% 8.66% -11.52% 4.08% -17.22% 14.07%
EBITDA Q/Q Growth
233.13% 2.07% 53.91% -21.79% 7.66% -30.23% 84.65% -20.91% 18.17% -67.11% 179.94%
EBIT Q/Q Growth
262.89% 5.79% 117.67% -31.52% 10.76% -49.51% 198.94% -19.82% 17.02% -97.79% 703.39%
NOPAT Q/Q Growth
223.75% -28.47% 162.69% -37.96% 15.24% -18.59% 81.11% -13.80% 5.04% -90.03% 443.17%
Net Income Q/Q Growth
-67.67% 53.70% 26.14% 2.28% 9.14% -18.73% 147.42% -821.65% 430.75% -112.20% 107.73%
EPS Q/Q Growth
-56.41% 60.66% 20.83% 5.26% 11.11% -25.00% 145.00% -822.22% 404.62% -104.04% 125.00%
Operating Cash Flow Q/Q Growth
321.84% 61.63% -170.91% 141.31% -1.14% 197.54% -197.41% -149.67% 116.74% 313.50% -196.32%
Free Cash Flow Firm Q/Q Growth
235.65% -12.00% -21.58% -29.39% 7.70% -29.78% -18.18% 333.55% -29.68% -66.12% 271.57%
Invested Capital Q/Q Growth
-2.54% -4.40% 4.24% -0.82% -2.82% -3.16% 6.33% -12.10% 1.71% -7.01% 7.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
60.28% 60.40% 58.99% 58.10% 57.86% 59.44% 57.03% 56.87% 56.22% 55.43% 55.94%
EBITDA Margin
12.25% 13.47% 18.20% 14.52% 15.68% 11.71% 19.90% 17.79% 20.19% 8.02% 22.30%
Operating Margin
7.05% 5.43% 12.53% 7.93% 9.17% 7.99% 13.31% 12.97% 13.09% 1.58% 15.25%
EBIT Margin
5.49% 6.26% 11.96% 8.36% 9.29% 5.02% 13.80% 12.51% 14.06% 0.38% 16.17%
Profit (Net Income) Margin
-28.08% -14.01% -9.08% -9.06% -8.26% -10.49% 4.58% -37.33% 118.64% -17.49% 1.05%
Tax Burden Percent
104.30% 121.96% 104.30% 107.36% 112.27% 82.07% -165.23% 233.73% -8,173.37% 106.10% -399.60%
Interest Burden Percent
-490.31% -183.55% -72.83% -100.96% -79.19% -254.76% -20.07% -127.72% -10.32% -4,383.78% -1.63%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
4.62% 3.81% 8.70% 5.64% 6.76% 6.18% 9.76% 9.18% 9.41% 1.26% 11.10%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.42% 0.76% 5.34% 2.98% 4.12% 3.45% 8.92% 1.82% 29.40% -1.68% 9.27%
Return on Net Nonoperating Assets (RNNOA)
5.75% -2.75% -18.74% -9.83% -12.51% -9.87% -26.29% -4.84% -93.26% 4.82% -28.97%
Return on Equity (ROE)
10.37% 1.06% -10.04% -4.18% -5.75% -3.69% -16.53% 4.34% -83.85% 6.08% -17.87%
Cash Return on Invested Capital (CROIC)
8.03% 9.71% 8.37% 9.68% 10.57% 10.05% 7.82% 20.27% 16.71% 12.22% 19.70%
Operating Return on Assets (OROA)
3.21% 3.78% 7.22% 5.19% 5.91% 3.27% 8.86% 7.52% 8.54% 0.23% 10.15%
Return on Assets (ROA)
-16.41% -8.46% -5.48% -5.62% -5.25% -6.83% 2.94% -22.44% 72.09% -10.61% 0.66%
Return on Common Equity (ROCE)
10.57% 1.07% -10.27% -4.27% -5.86% -3.76% -16.84% 4.42% -85.71% 6.20% -18.25%
Return on Equity Simple (ROE_SIMPLE)
45.64% 0.00% 34.58% 29.56% 19.26% 0.00% 10.93% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
37 26 69 43 49 40 72 62 66 6.54 81
NOPAT Margin
4.93% 3.80% 8.77% 5.55% 6.42% 5.59% 9.32% 9.08% 9.16% 1.10% 10.67%
Net Nonoperating Expense Percent (NNEP)
6.04% 3.04% 3.36% 2.67% 2.64% 2.72% 0.84% 7.36% -19.99% 2.94% 1.83%
Return On Investment Capital (ROIC_SIMPLE)
1.03% 0.76% 1.93% 1.21% 1.41% 1.15% 2.03% 1.93% 2.01% 0.20% 2.50%
Cost of Revenue to Revenue
39.72% 39.60% 41.01% 41.90% 42.14% 40.56% 42.97% 43.13% 43.78% 44.57% 44.06%
SG&A Expenses to Revenue
20.36% 20.40% 18.06% 21.59% 21.06% 21.63% 18.45% 18.80% 19.64% 24.40% 17.62%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
53.23% 54.97% 46.46% 50.17% 48.69% 51.45% 43.72% 43.90% 43.13% 53.86% 40.70%
Earnings before Interest and Taxes (EBIT)
41 43 94 64 71 36 107 86 101 2.23 123
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
91 93 142 111 120 84 155 122 144 47 170
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.52 0.57 0.31 0.34 0.47 0.46 0.36 0.45 0.26 0.19 0.20
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.31 1.02 1.15
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 76.60% 97.69% 86.81%
Enterprise Value to Invested Capital (EV/IC)
1.96 2.10 1.82 1.88 2.06 2.12 1.92 2.30 1.66 1.66 1.63
Enterprise Value to Revenue (EV/Rev)
2.00 2.01 1.78 1.81 1.92 1.89 1.83 2.13 1.55 1.44 1.48
Enterprise Value to EBITDA (EV/EBITDA)
32.85 21.86 14.91 12.35 12.37 12.53 11.79 13.29 8.85 8.49 8.32
Enterprise Value to EBIT (EV/EBIT)
0.00 95.88 34.54 22.37 21.22 21.67 19.90 21.68 13.67 13.45 12.87
Enterprise Value to NOPAT (EV/NOPAT)
0.00 176.93 51.67 31.04 30.92 28.62 27.13 28.93 18.82 19.24 18.65
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 103.82 86.87 46.76 68.76 81.21 95.30 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
23.29 20.71 21.14 19.03 19.13 20.80 24.50 10.63 9.51 13.37 7.80
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-3.80 -3.55 -3.52 -3.39 -3.29 -3.18 -3.31 -2.81 -4.49 -4.25 -4.21
Long-Term Debt to Equity
-3.80 -3.55 -3.52 -3.24 -3.13 -3.04 -3.16 -2.79 -4.32 -4.01 -3.86
Financial Leverage
-4.05 -3.60 -3.51 -3.30 -3.04 -2.86 -2.95 -2.65 -3.17 -2.86 -3.12
Leverage Ratio
-4.88 -4.31 -4.13 -3.77 -3.37 -3.15 -3.18 -2.78 -3.67 -3.49 -3.52
Compound Leverage Factor
23.93 7.92 3.01 3.80 2.67 8.03 0.64 3.55 0.38 153.10 0.06
Debt to Total Capital
135.69% 139.21% 139.65% 141.84% 143.65% 145.83% 143.31% 155.20% 128.67% 130.82% 131.18%
Short-Term Debt to Total Capital
0.11% 0.12% 0.09% 6.16% 6.99% 6.63% 6.52% 1.31% 4.67% 7.39% 10.91%
Long-Term Debt to Total Capital
135.57% 139.10% 139.56% 135.68% 136.66% 139.20% 136.79% 153.89% 124.00% 123.43% 120.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.76% 0.78% 0.78% 0.79% 0.79% 0.79% 0.77% 0.84% 0.82% 0.80% 0.81%
Common Equity to Total Capital
-36.44% -39.99% -40.43% -42.63% -44.44% -46.62% -44.08% -56.04% -29.50% -31.61% -31.99%
Debt to EBITDA
27.81 18.09 14.13 11.46 10.80 11.07 10.90 11.50 8.76 9.28 8.50
Net Debt to EBITDA
24.09 15.50 12.23 9.96 9.27 9.39 9.42 10.43 7.29 7.29 7.13
Long-Term Debt to EBITDA
27.79 18.08 14.12 10.96 10.27 10.57 10.40 11.40 8.44 8.76 7.79
Debt to NOPAT
-153.06 146.47 48.99 28.79 27.00 25.29 25.08 25.04 18.63 21.02 19.04
Net Debt to NOPAT
-132.60 125.51 42.38 25.02 23.18 21.45 21.68 22.70 15.51 16.51 15.98
Long-Term Debt to NOPAT
-152.93 146.35 48.96 27.54 25.69 24.14 23.94 24.82 17.95 19.84 17.46
Altman Z-Score
-0.32 -0.33 -0.36 -0.45 -0.44 -0.49 -0.43 -0.64 -0.36 -0.49 -0.44
Noncontrolling Interest Sharing Ratio
-1.90% -1.73% -2.30% -2.14% -1.95% -1.84% -1.86% -1.69% -2.21% -2.06% -2.11%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.32 1.27 1.37 1.07 1.02 1.02 1.10 1.01 1.14 1.07 0.93
Quick Ratio
1.10 1.08 1.17 0.91 0.92 0.93 0.94 0.80 1.02 0.91 0.82
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
313 275 216 152 164 115 94 409 287 97 393
Operating Cash Flow to CapEx
290.93% 510.39% -246.03% 139.83% 137.27% 514.07% -977.01% -930.24% 166.19% 593.54% -631.94%
Free Cash Flow to Firm to Interest Expense
2.58 0.00 1.33 0.00 0.00 0.00 0.00 4.80 0.00 17.71 144.04
Operating Cash Flow to Interest Expense
0.49 0.00 -0.42 0.00 0.00 0.00 0.00 -2.36 0.00 25.33 -49.18
Operating Cash Flow Less CapEx to Interest Expense
0.32 0.00 -0.59 0.00 0.00 0.00 0.00 -2.62 0.00 21.07 -56.96
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.60 0.60 0.62 0.64 0.65 0.64 0.60 0.61 0.61 0.63
Accounts Receivable Turnover
7.19 8.34 7.14 7.28 7.49 8.87 7.48 7.74 6.98 9.26 7.40
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
12.26 12.56 12.45 12.34 12.42 12.57 12.24 11.08 11.05 11.33 11.05
Accounts Payable Turnover
6.77 5.91 5.45 5.33 5.39 5.07 4.98 4.80 5.10 4.80 5.30
Days Sales Outstanding (DSO)
50.78 43.75 51.12 50.12 48.74 41.17 48.80 47.16 52.26 39.42 49.30
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
53.88 61.80 67.03 68.51 67.69 72.06 73.24 76.01 71.57 76.06 68.85
Cash Conversion Cycle (CCC)
-3.10 -18.05 -15.90 -18.40 -18.95 -30.89 -24.44 -28.84 -19.31 -36.64 -19.55
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,908 2,780 2,898 2,875 2,793 2,705 2,876 2,528 2,572 2,391 2,565
Invested Capital Turnover
0.94 1.00 0.99 1.02 1.05 1.10 1.05 1.01 1.03 1.14 1.04
Increase / (Decrease) in Invested Capital
-276 -249 -147 -110 -115 -75 -22 -346 -222 -91 -312
Enterprise Value (EV)
5,695 5,839 5,260 5,399 5,767 5,733 5,535 5,823 4,260 3,979 4,178
Market Capitalization
1,492 1,670 918 1,020 1,416 1,408 1,085 1,225 722 537 573
Book Value per Share
($3.90) ($3.66) ($3.80) ($3.94) ($4.04) ($4.20) ($4.08) ($4.69) ($2.45) ($2.66) ($2.63)
Tangible Book Value per Share
($12.74) ($11.38) ($11.49) ($11.56) ($11.57) ($11.69) ($11.54) ($11.62) ($9.23) ($9.42) ($9.36)
Total Capital
3,553 3,472 3,572 3,530 3,505 3,473 3,571 3,247 3,277 3,324 3,252
Total Debt
4,821 4,834 4,988 5,007 5,035 5,065 5,118 5,040 4,216 4,349 4,266
Total Long-Term Debt
4,817 4,829 4,985 4,789 4,790 4,835 4,885 4,997 4,063 4,103 3,912
Net Debt
4,176 4,142 4,314 4,351 4,323 4,297 4,423 4,570 3,511 3,416 3,579
Capital Expenditures (CapEx)
20 19 28 20 20 16 8.25 22 20 23 21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-331 -421 -313 -336 -422 -494 -332 -399 -391 -582 -402
Debt-free Net Working Capital (DFNWC)
292 248 337 298 268 252 340 48 292 328 263
Net Working Capital (NWC)
288 244 334 81 23 21 107 5.91 139 82 -92
Net Nonoperating Expense (NNE)
244 122 140 112 112 115 37 319 -783 110 73
Net Nonoperating Obligations (NNO)
4,176 4,142 4,314 4,351 4,323 4,297 4,423 4,321 3,511 3,416 3,579
Total Depreciation and Amortization (D&A)
50 50 49 47 49 48 47 36 44 45 47
Debt-free, Cash-free Net Working Capital to Revenue
-11.59% -14.49% -10.62% -11.27% -14.06% -16.30% -10.99% -14.60% -14.18% -21.00% -14.19%
Debt-free Net Working Capital to Revenue
10.24% 8.53% 11.44% 10.01% 8.92% 8.31% 11.24% 1.77% 10.61% 11.84% 9.30%
Net Working Capital to Revenue
10.10% 8.39% 11.33% 2.71% 0.76% 0.71% 3.53% 0.22% 5.05% 2.98% -3.24%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.61) ($0.24) ($0.19) ($0.18) ($0.16) ($0.20) $0.09 ($0.65) $2.15 ($0.25) $0.02
Adjusted Weighted Average Basic Shares Outstanding
345.13M 346.57M 379.77M 383.51M 385.73M 383.73M 386.27M 390.91M 394.58M 391.71M 395.15M
Adjusted Diluted Earnings per Share
($0.61) ($0.24) ($0.19) ($0.18) ($0.16) ($0.20) $0.09 ($0.65) $1.98 ($0.08) $0.02
Adjusted Weighted Average Diluted Shares Outstanding
345.13M 346.57M 379.77M 383.51M 385.73M 383.73M 455.26M 390.91M 429.25M 391.71M 397.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
379.48M 379.48M 381.93M 385.70M 385.85M 386.01M 387.81M 394.51M 394.88M 395.17M 395.31M
Normalized Net Operating Profit after Tax (NOPAT)
37 26 69 43 49 40 72 62 66 6.54 81
Normalized NOPAT Margin
4.93% 3.80% 8.77% 5.55% 6.42% 5.59% 9.32% 9.08% 9.16% 1.10% 10.67%
Pre Tax Income Margin
-26.92% -11.49% -8.71% -8.44% -7.35% -12.78% -2.77% -15.97% -1.45% -16.48% -0.26%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.34 0.00 0.58 0.00 0.00 0.00 0.00 1.01 0.00 0.40 45.06
NOPAT to Interest Expense
0.30 0.00 0.42 0.00 0.00 0.00 0.00 0.73 0.00 1.19 29.74
EBIT Less CapEx to Interest Expense
0.17 0.00 0.41 0.00 0.00 0.00 0.00 0.75 0.00 -3.86 37.28
NOPAT Less CapEx to Interest Expense
0.13 0.00 0.25 0.00 0.00 0.00 0.00 0.48 0.00 -3.08 21.96
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-3.62% -3.04% -2.14% -1.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-3.62% -3.04% -2.14% -1.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, data-driven snapshot of Sabre Corp (SABR) using the last four years of quarterly results. The focus is on trends in revenue, profitability, cash flow, and leverage to help retail investors gauge how the business has evolved.

  • Solid gross margin in 2024–2025. In Q4 2025 Sabre posted operating revenue of $592.0M with gross profit of $328.2M (total gross margin around 55%). This mirrors a historically robust gross margin, with Q3 2025 gross margin around 56% (402.1M on 715.2M) and Q4 2024 around 59% (424.8M on 714.7M).
  • Small but positive operating income in Q4 2025. Operating income reached about $9.3M, signaling a move toward positive operating performance despite overall revenue volatility.
  • Healthy near-term cash flow from operations in Q4 2025. Net cash from continuing operating activities was about $139.3M, marking a solid cash-creating quarter.
  • Positive financing activity in Q4 2025. Net cash from financing activities totaled roughly $118.7M, supported by debt issuance during the period (see next bullet).
  • Significant debt financing in Q4 2025. Issuance of debt was about $1.787B, providing substantial liquidity for liquidity or strategic moves, even as leverage remains high.
  • Big one-time net income impact in Q3 2025. Net income attributable to common shareholders in Q3 2025 was roughly $848.7M, largely driven by a large discontinued-operations gain, which can distort trailing earnings but boosts reported profitability that quarter.
  • Strong quarterly cash change in Q4 2025. Net change in cash and equivalents rose by about $227.4M, reflecting the combined effects of cash from operations, investing, and financing in that quarter.
  • Revenue swings indicate seasonality and mix effects. Quarterly revenue moved from about $592M (Q4 2025) to $715M (Q3 2025) and $687M (Q2 2025) and $777M (Q1 2025), signaling notable quarter-to-quarter variability.
  • Debt load and leverage remain substantial. Long-term debt sits in the mid-to-high $4B range across recent quarters, contributing to ongoing interest expense and balance-sheet leverage concerns.
  • Persistent net losses and negative book equity in several periods. Sabre’s quarterly results show meaningful net losses across many quarters (e.g., Q4 2024 and Q3 2024) and, in mid-2025 balance sheets, total liabilities exceeded assets with negative equity, highlighting ongoing profitability and solvency challenges.
05/14/26 12:00 AM ETAI Generated. May Contain Errors.

Sabre Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sabre's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Sabre's net income appears to be on an upward trend, with a most recent value of $523.96 million in 2025, falling from $548.96 million in 2015. The previous period was -$278.68 million in 2024. Find out what analysts predict for Sabre in the coming months.

Sabre's total operating income in 2025 was $295.50 million, based on the following breakdown:
  • Total Gross Profit: $1.56 billion
  • Total Operating Expenses: $1.27 billion

Over the last 10 years, Sabre's total revenue changed from $2.96 billion in 2015 to $2.77 billion in 2025, a change of -6.4%.

Sabre's total liabilities were at $5.53 billion at the end of 2025, a 11.2% decrease from 2024, and a 12.6% increase since 2015.

In the past 10 years, Sabre's cash and equivalents has ranged from $321.13 million in 2015 to $1.50 billion in 2020, and is currently $791.56 million as of their latest financial filing in 2025.

Over the last 10 years, Sabre's book value per share changed from 1.74 in 2015 to -2.66 in 2025, a change of -253.0%.



Financial statements for NASDAQ:SABR last updated on 5/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners